ARTICLE | Clinical News
Vadadustat: Phase III started
August 22, 2016 7:00 AM UTC
Akebia began the open-label, international Phase III INNO2VATE-Correction trial to compare oral vadadustat vs. subcutaneous or IV Aranesp darbepoetin alfa in about 400 treatment-naive, dialysis-depen...